Document is current
Any future updates will be listed below
-
Authors
Igarashi, Hiroyuki
Uchino, Hiroshi
Kanaguchi, Momoko
Hisanaga, Kaori
Sato, Genki
Yoshikawa, Fukumi
Furuta, Masashi
Washizawa, Naohiro
Usui, Shuki
Miyagi, Masahiko
Hirose, Takahisa
-
Funding
Funding for this research was provided by:
Mitsubishi Tanabe Pharma Corporation (3235)
- License Information
-
More Information
Article History
Received: 8 December 2022
Accepted: 6 February 2023
First Online: 19 February 2023
Declarations
:
: The protocol was reviewed by the Japanese authorities in accordance with local regulations followed by review and approval by the institutional review board of Toho University Omori Medical Center (M1618917, 11717238). The consent to participate and consent to publish are also review and approved. The study was conducted in accordance with the International Conference on Harmonization Guidelines for Good Clinical Practice and the Declaration of Helsinki [CitationRef removed]. The study was registered with the National University Hospital Medical Information Network (UMIN Clinical Trials Registry: UMIN0000 27262).
: The authors have no competing interests as defined by BMC, or other interests that might be perceived to influence the results and/or discussion reported in this paper.
